We are proud to announce the expansion of our fleet with new dedicated radiopharma vehicles, further enhancing our licensed network for the transport of medical isotopes used in diagnostics and therapy. These vehicles are engineered to meet the highest standards for the safe and efficient delivery of radiopharmaceuticals by both road and air, offering comprehensive global support to healthcare facilities and production plants.

The newly added vehicles are equipped with state-of-the-art temperature-controlled systems, ADR-compliant technology, and GPS geolocation to ensure precise tracking. Fully compliant with Class 7 regulations across all operational territories, these vehicles reflect PHSE’s unwavering commitment to safety, reliability, and efficiency in the transport of radiopharmaceuticals.

This initiative underscores PHSE’s leadership in radiopharmaceutical logistics, delivering innovative and reliable solutions that prioritize patient care and operational excellence.

Milan, 12 november 2024 – In the report published today on Il Sole 24 Ore, we are among the Italy’s Growth Champions 2025. The award is dedicated to the 500 Italian companies that have experienced the highest revenue growth in the three-year period from 2020 to 2023.

It is a significant public recognition that confirms the high potential of our company, capable of competing increasingly on the international stage.

With an average annual growth of 40% PHSE ranks 293.

Check out the complete list of 500 companies, compiled by il Sole 24 Ore and Statista.

The rankings are available online at the following link:

Ranking Leader della Crescita 2025

Here, the link to the online dossier:

Dossier Leader della Crescita 2025

We are delighted to share our participation at The ONE Forum, organized by the National Marrow Donor Program (NMDP) in Minneapolis. This unique and impactful event brought together over 2,000 professionals from the cell therapy ecosystem to collaborate and shape the future of this life-saving field.

Representing the PHSE Group, our teams from PHSE and Bio Transportes – a PHSE company proudly contributed to this visionary event. Together, we share NMDP’s mission to expand access to life-saving cell therapies for patients battling cancer and blood diseases.

At PHSE, we specialize in providing the highest standard of logistics for time-critical and temperature-sensitive shipments, ensuring patient safety and reliability. Our solutions include:

• Time-Critical and Temperature-Sensitive Logistics: From donor to patient, we handle every step, including temperature-controlled air freight, onboard couriers, last-mile distribution, and white-glove logistics services.
• Global Reliability and Security: We ensure shipments are 100% secure and reliable anywhere in the world.
• Route Risk Assessments: Our meticulous planning ensures zero-defect shipments every time.
• Transparency and Traceability: We provide global temperature and location monitoring for every shipment.
• Certified Packaging Solutions: Our certified thermal parcels and cryogenic dewars guarantee the integrity of cell therapy materials.
• 24/7 Support: Always available, always responsive.

We are honored to have been among the sponsors of this influential event, contributing to a shared vision of improving patient outcomes through innovative logistics solutions. By supporting initiatives like The ONE Forum, we reaffirm our commitment to advancing access to transformative therapies and improving lives worldwide.